In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)
Open Access
- 1 November 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (5) , 785-786
- https://doi.org/10.1128/aac.26.5.785
Abstract
About 80% of 70 clinical isolates of Bacteroides fragilis were inhibited by 4 micrograms of ciprofloxacin (Bay o 9867) per ml. The 90% MIC of ciprofloxacin was 8 micrograms/ml for other Bacteroides species, 2 micrograms/ml for Peptococcus species, 8 micrograms/ml for Peptostreptococcus species, and 16 micrograms/ml for Clostridium and Eubacterium species.Keywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- In Vitro Activity of Ticarcillin Against Anaerobic Bacteria Compared with That of Carbenicillin and PenicillinAntimicrobial Agents and Chemotherapy, 1977
- Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.1969